Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease

Huntington’s disease (HD) is a fatal neurodegenerative disorder with no effective cure currently available. Over the past few years our research has shown that alterations in sphingolipid metabolism represent a critical determinant in HD pathogenesis. In particular, aberrant metabolism of sphingosin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pepe, Giuseppe (VerfasserIn) , Capocci, Luca (VerfasserIn) , Marracino, Federico (VerfasserIn) , Realini, Natalia (VerfasserIn) , Lenzi, Paola (VerfasserIn) , Martinello, Katiuscia (VerfasserIn) , Bovier, Tiziana Francesca (VerfasserIn) , Bichell, Terry Jo (VerfasserIn) , Scarselli, Pamela (VerfasserIn) , Di Cicco, Clotilde (VerfasserIn) , Bowman, Aaron B. (VerfasserIn) , Digilio, Filomena A. (VerfasserIn) , Fucile, Sergio (VerfasserIn) , Fornai, Francesco (VerfasserIn) , Armirotti, Andrea (VerfasserIn) , Parlato, Rosanna (VerfasserIn) , Di Pardo, Alba (VerfasserIn) , Maglione, Vittorio (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 4 January 2023
In: Molecular therapy
Year: 2023, Jahrgang: 31, Heft: 1, Pages: 282-299
ISSN:1525-0024
DOI:10.1016/j.ymthe.2022.09.004
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ymthe.2022.09.004
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1525001622005585
Volltext
Verfasserangaben:Giuseppe Pepe, Luca Capocci, Federico Marracino, Natalia Realini, Paola Lenzi, Katiuscia Martinello, Tiziana Francesca Bovier, Terry Jo Bichell, Pamela Scarselli, Clotilde Di Cicco, Aaron B. Bowman, Filomena A. Digilio, Sergio Fucile, Francesco Fornai, Andrea Armirotti, Rosanna Parlato, Alba Di Pardo, Vittorio Maglione

MARC

LEADER 00000caa a22000002c 4500
001 1847490484
003 DE-627
005 20230706204745.0
007 cr uuu---uuuuu
008 230606s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ymthe.2022.09.004  |2 doi 
035 |a (DE-627)1847490484 
035 |a (DE-599)KXP1847490484 
035 |a (OCoLC)1389529872 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pepe, Giuseppe  |d 1974-  |e VerfasserIn  |0 (DE-588)129604755  |0 (DE-627)707278899  |0 (DE-576)297744976  |4 aut 
245 1 0 |a Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease  |c Giuseppe Pepe, Luca Capocci, Federico Marracino, Natalia Realini, Paola Lenzi, Katiuscia Martinello, Tiziana Francesca Bovier, Terry Jo Bichell, Pamela Scarselli, Clotilde Di Cicco, Aaron B. Bowman, Filomena A. Digilio, Sergio Fucile, Francesco Fornai, Andrea Armirotti, Rosanna Parlato, Alba Di Pardo, Vittorio Maglione 
246 3 0 |a one 
264 1 |c 4 January 2023 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 16. September 2022, Artikelversion 4. Januar 2023 
500 |a Gesehen am 06.06.2023 
520 |a Huntington’s disease (HD) is a fatal neurodegenerative disorder with no effective cure currently available. Over the past few years our research has shown that alterations in sphingolipid metabolism represent a critical determinant in HD pathogenesis. In particular, aberrant metabolism of sphingosine-1-phosphate (S1P) has been reported in multiple disease settings, including human postmortem brains from HD patients. In this study, we investigate the potential therapeutic effect of the inhibition of S1P degradative enzyme SGPL1, by the chronic administration of the 2-acetyl-5-tetrahydroxybutyl imidazole (THI) inhibitor. We show that THI mitigated motor dysfunctions in both mouse and fly models of HD. The compound evoked the activation of pro-survival pathways, normalized levels of brain-derived neurotrophic factor, preserved white matter integrity, and stimulated synaptic functions in HD mice. Metabolically, THI restored normal levels of hexosylceramides and stimulated the autophagic and lysosomal machinery, facilitating the reduction of nuclear inclusions of both wild-type and mutant huntingtin proteins. 
650 4 |a glucosylceramide 
650 4 |a HD 
650 4 |a Htt 
650 4 |a neurodegeneration 
650 4 |a neuroprotection 
650 4 |a therapeutics 
650 4 |a THI 
700 1 |a Capocci, Luca  |e VerfasserIn  |4 aut 
700 1 |a Marracino, Federico  |e VerfasserIn  |4 aut 
700 1 |a Realini, Natalia  |e VerfasserIn  |4 aut 
700 1 |a Lenzi, Paola  |e VerfasserIn  |4 aut 
700 1 |a Martinello, Katiuscia  |e VerfasserIn  |4 aut 
700 1 |a Bovier, Tiziana Francesca  |e VerfasserIn  |4 aut 
700 1 |a Bichell, Terry Jo  |e VerfasserIn  |4 aut 
700 1 |a Scarselli, Pamela  |e VerfasserIn  |4 aut 
700 1 |a Di Cicco, Clotilde  |e VerfasserIn  |4 aut 
700 1 |a Bowman, Aaron B.  |e VerfasserIn  |4 aut 
700 1 |a Digilio, Filomena A.  |e VerfasserIn  |4 aut 
700 1 |a Fucile, Sergio  |e VerfasserIn  |4 aut 
700 1 |a Fornai, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Armirotti, Andrea  |e VerfasserIn  |4 aut 
700 1 |a Parlato, Rosanna  |d 1973-  |e VerfasserIn  |0 (DE-588)1064026451  |0 (DE-627)812875338  |0 (DE-576)415235642  |4 aut 
700 1 |a Di Pardo, Alba  |e VerfasserIn  |4 aut 
700 1 |a Maglione, Vittorio  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Molecular therapy  |d Amsterdam : Elsevier, 2000  |g 31(2023), 1 vom: Jan., Seite 282-299  |h Online-Ressource  |w (DE-627)320415198  |w (DE-600)2001818-6  |w (DE-576)104344695  |x 1525-0024  |7 nnas  |a Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease 
773 1 8 |g volume:31  |g year:2023  |g number:1  |g month:01  |g pages:282-299  |g extent:18  |a Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease 
856 4 0 |u https://doi.org/10.1016/j.ymthe.2022.09.004  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S1525001622005585  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230606 
993 |a Article 
994 |a 2023 
998 |g 1064026451  |a Parlato, Rosanna  |m 1064026451:Parlato, Rosanna  |d 60000  |d 62700  |e 60000PP1064026451  |e 62700PP1064026451  |k 0/60000/  |k 1/60000/62700/  |p 16 
999 |a KXP-PPN1847490484  |e 4329637014 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Pepe, Giuseppe","given":"Giuseppe","family":"Pepe","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Luca","family":"Capocci","role":"aut","roleDisplay":"VerfasserIn","display":"Capocci, Luca"},{"display":"Marracino, Federico","role":"aut","roleDisplay":"VerfasserIn","given":"Federico","family":"Marracino"},{"display":"Realini, Natalia","roleDisplay":"VerfasserIn","role":"aut","given":"Natalia","family":"Realini"},{"display":"Lenzi, Paola","roleDisplay":"VerfasserIn","role":"aut","family":"Lenzi","given":"Paola"},{"display":"Martinello, Katiuscia","role":"aut","roleDisplay":"VerfasserIn","given":"Katiuscia","family":"Martinello"},{"given":"Tiziana Francesca","family":"Bovier","role":"aut","roleDisplay":"VerfasserIn","display":"Bovier, Tiziana Francesca"},{"display":"Bichell, Terry Jo","family":"Bichell","given":"Terry Jo","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Scarselli, Pamela","roleDisplay":"VerfasserIn","role":"aut","given":"Pamela","family":"Scarselli"},{"display":"Di Cicco, Clotilde","role":"aut","roleDisplay":"VerfasserIn","family":"Di Cicco","given":"Clotilde"},{"display":"Bowman, Aaron B.","role":"aut","roleDisplay":"VerfasserIn","given":"Aaron B.","family":"Bowman"},{"display":"Digilio, Filomena A.","family":"Digilio","given":"Filomena A.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Sergio","family":"Fucile","role":"aut","roleDisplay":"VerfasserIn","display":"Fucile, Sergio"},{"display":"Fornai, Francesco","given":"Francesco","family":"Fornai","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","role":"aut","family":"Armirotti","given":"Andrea","display":"Armirotti, Andrea"},{"given":"Rosanna","family":"Parlato","role":"aut","roleDisplay":"VerfasserIn","display":"Parlato, Rosanna"},{"display":"Di Pardo, Alba","family":"Di Pardo","given":"Alba","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Vittorio","family":"Maglione","roleDisplay":"VerfasserIn","role":"aut","display":"Maglione, Vittorio"}],"relHost":[{"id":{"eki":["320415198"],"zdb":["2001818-6"],"issn":["1525-0024"]},"origin":[{"dateIssuedKey":"2000","publisher":"Elsevier ; Nature Publ. Group ; Acad. Press","dateIssuedDisp":"2000-","publisherPlace":"Amsterdam ; New York, NY ; Orlando, Fla."}],"note":["Gesehen am 28.05.2020"],"type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"roleDisplay":"Herausgebendes Organ","role":"isb","display":"American Society of Gene Therapy"}],"recId":"320415198","language":["eng"],"pubHistory":["1.2000 -"],"title":[{"title_sort":"Molecular therapy","title":"Molecular therapy","subtitle":"official journal of the American Society of Gene Therapy"}],"disp":"Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s diseaseMolecular therapy","part":{"year":"2023","text":"31(2023), 1 vom: Jan., Seite 282-299","volume":"31","extent":"18","issue":"1","pages":"282-299"},"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1847490484"],"doi":["10.1016/j.ymthe.2022.09.004"]},"title":[{"title":"Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease","title_sort":"Treatment with THI, an inhibitor of sphingosine-1-phosphate lyase, modulates glycosphingolipid metabolism and results therapeutically effective in experimental models of Huntington’s disease"}],"language":["eng"],"recId":"1847490484","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online verfügbar 16. September 2022, Artikelversion 4. Januar 2023","Gesehen am 06.06.2023"],"origin":[{"dateIssuedDisp":"4 January 2023","dateIssuedKey":"2023"}],"physDesc":[{"extent":"18 S."}],"name":{"displayForm":["Giuseppe Pepe, Luca Capocci, Federico Marracino, Natalia Realini, Paola Lenzi, Katiuscia Martinello, Tiziana Francesca Bovier, Terry Jo Bichell, Pamela Scarselli, Clotilde Di Cicco, Aaron B. Bowman, Filomena A. Digilio, Sergio Fucile, Francesco Fornai, Andrea Armirotti, Rosanna Parlato, Alba Di Pardo, Vittorio Maglione"]}} 
SRT |a PEPEGIUSEPTREATMENTW4202